Crews Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Crews Bank & Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243K	Sell	4,221 -169	-4%	-$9.7K	0.03%	211
2026 Q1	$266K	Sell	4,390 -409	-9%	-$23.8K	0.04%	195
2025 Q4	$259K	Sell	4,799 -452	-9%	-$21.7K	0.04%	192
2025 Q3	$237K	Sell	5,251 -1,275	-20%	-$59.5K	0.03%	205
2025 Q2	$302K	Buy	6,526 +1,135	+21%	+$55.7K	0.05%	188
2025 Q1	$329K	Sell	5,391 -531	-9%	-$31K	0.06%	175
2024 Q4	$335K	Buy	+5,922	New	+$331K	0.06%	172

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Crews Bank & Trust's BMY Position: Q2 2026 in Review

Crews Bank & Trust reduced its Bristol-Myers Squibb (BMY) stake by 3.8% in Q2 2026, selling an estimated $9.7K and leaving 4,221 shares worth $243K. The position accounts for 0.03% of the portfolio, ranked #211.

Crews Bank & Trust first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $335K in Q4 2024. 848 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Crews Bank & Trust held 4,221 shares of Bristol-Myers Squibb worth $243K as of Q2 2026.
Crews Bank & Trust sold 169 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.7K.
Bristol-Myers Squibb made up 0.03% of Crews Bank & Trust's portfolio in Q2 2026, its #211 holding.
Crews Bank & Trust first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
Crews Bank & Trust's Bristol-Myers Squibb position peaked at $335K in Q4 2024.
848 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Crews Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.